Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000082

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 21, 2018
Accepted (ET)
Dec 31, 2018 · 1:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 21, 2018P5,000$0.0182A26,510,898D
Common StockDec 21, 2018P5,000$0.0182A26,515,898D
Common StockDec 21, 2018P10,000$0.02A26,525,898D
Common StockDec 21, 2018P5,000$0.02A26,530,898D
Common StockDec 21, 2018P3,000$0.02A26,533,898D
Common StockDec 21, 2018P3,000$0.022A26,536,898D
Common StockDec 21, 2018P1,000$0.022A26,537,898D
Common StockDec 21, 2018P2,000$0.022A26,539,898D
Common StockDec 21, 2018P3,000$0.022A26,542,898D
Common StockDec 21, 2018P3,000$0.022A26,545,898D
Common StockDec 21, 2018P4,000$0.022A26,549,898D
Common StockDec 21, 2018P900$0.022A26,550,798D
Common StockDec 21, 2018P4,100$0.022A26,554,898D
Common StockDec 21, 2018P5,000$0.0216A26,559,898D
Common StockDec 21, 2018P3,000$0.0218A26,562,898D
Common StockDec 21, 2018P2,000$0.022A26,564,898D
Common StockDec 21, 2018P3,000$0.0216A26,567,898D
Common StockDec 24, 2018P1,000$0.0223A26,568,898D
Common StockDec 24, 2018P1,000$0.0223A26,569,898D
Common StockDec 24, 2018P2,000$0.0226A26,571,898D
Common StockDec 24, 2018P1,000$0.0216A26,572,898D
Common StockDec 24, 2018P1,000$0.0219A26,573,898D
Common StockDec 24, 2018P2,000$0.0219A26,575,898D
Common StockDec 24, 2018P2,000$0.0208A26,577,898D
Common StockDec 24, 2018P3,000$0.021A26,580,898D
Common StockDec 24, 2018P2,000$0.021A26,582,898D
Common StockDec 24, 2018P3,000$0.021A26,585,898D
Common StockDec 24, 2018P2,000$0.0208A26,587,898D
Common StockDec 24, 2018P199$0.0208A26,588,097D
Common StockDec 24, 2018P1,000$0.0208A26,589,097D

Table II — derivative securities

No Table II lines on this filing.